Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prosthesis Failure × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 284 Carcinoma, Non-Small-Cell Lung 217 Ovarian Neoplasms 148 Lung Neoplasms 110 Neoplasms 77 Fallopian Tube Neoplasms 61 Carcinoma, Ovarian Epithelial 57 Neoplasm Metastasis 52 Esophageal Neoplasms 51 Stomach Neoplasms 44 Head and Neck Neoplasms 38 Squamous Cell Carcinoma of Head and Neck 36 Triple Negative Breast Neoplasms 33 Endometrial Neoplasms 27 Urinary Bladder Neoplasms 26 Adenocarcinoma of Lung 26 Unspecified Adult Solid Tumor, Protocol Specific 22 Melanoma 21 Esophageal Squamous Cell Carcinoma 21 Breast Neoplasms, Male 21 Recurrence 19 Uterine Cervical Neoplasms 18 Prostatic Neoplasms 18 Adenocarcinoma Of Esophagus 18 Carcinoma 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Small Cell Lung Carcinoma 15 Adenocarcinoma, Bronchiolo-Alveolar 15 Peritoneal Neoplasms 14 Brenner Tumor 14

Interventions

Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡